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Objectives: The aim of this project was to determine if strategies designed to increase self-
efficacy would improve smoking cessation rates in an adult outpatient population when 
compared to traditional smoking cessation practices. 
Background: There are many challenges when individuals try to quit. Inability to quit and 
relapse are common. Identifying the most effective strategies to address both the physical and 
behavioral aspects of nicotine dependence is necessary to support smoking abstinence. In the 
literature, a causal relationship exists between high levels of self-efficacy and improved smoking 
cessation rates.  
Methods: A feasibility study, using a pre- post-test design was used to explore whether 
strategies designed to increase self-efficacy increased the ability of individuals to quit smoking. 
The researcher designed strategies to increase self-efficacy modeled after two theoretical 
frameworks: Albert Bandura’s Social Cognitive Theory and James Prochaska’s Transtheoretical 
Model of Change. Ten patients enrolled in this study. There was no random assignment and 
participants did not have the same chance of being in the control or experimental group.  The 
first five patients received standard treatment and the next five patients received enhanced self-
efficacy treatment. The goal was to identify increased quit rates in the five patients receiving the 
treatment.  
Results: Participants did not complete scheduled follow-up appointments so data obtained from 
the initial assessment could not be compared with subsequent assessments.  
Conclusions: Individuals quitting tobacco have many challenges and are best addressed by the 
combination of medication and behavioral modification to support smoking cessation. An 
improvement in smoking cessation outcomes may be influenced by the addition of methods 
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designed to increase a person’s level of self-efficacy or belief they can truly quit smoking.  
Creating more rigorous measures for patient accountability and follow-up are suggested to 




Background and Significance 
Cigarette smoking is the leading cause of preventable morbidity and mortality in the 
United States (Center for Disease Control [CDC], 2014). Each year, an estimated 443,000 people 
die from smoking related diseases (CDC, 2014). Smoking can contribute to the progression of 
diseases like coronary artery disease, chronic obstructive pulmonary disease, and lung cancer and 
result in poorer health outcomes (CDC, 2014). Nicotine found in tobacco is a highly addictive 
substance making it difficult for users to quit. When nicotine is absorbed into the blood stream, 
there is a neural-chemical response in the brain that releases feel good chemicals influencing the 
habitual use of tobacco for people experiencing depression, anxiety, sadness or boredom 
(Anthenelli, 2014). Because nicotine is addictive, it is hard for many people to quit tobacco. For 
“at risk” populations smoking prevalence may be greater due to sociodemographic and 
environmental factors that promote stress and increase the likelihood of using tobacco. In the 
United States, adult smoking rates have dropped from 24.7% in 1997 to 18.9% in 2012 (Egan, 
2013). Though the incidence of smoking is decreasing among adults, statistics show that 
disparities exist when evaluated by race, education, and socioeconomic status (Fernander, 
Resnicow, Viswantath & Perez-Stable, 2001).  
Disparities 
 When the prevalence of smoking statistics are categorized by race/ethnicity, Native 
Americans account for 31.4%, Asians 9.2%, African American 20.6%, Hispanics 12.5%, and 
Whites 21% (CDC, 2013). “While blacks and whites have similar smoking rates, blacks smoke 
fewer cigarettes per day than whites, yet blacks have [a] disproportionately larger incidence and 
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mortality rates for some smoking related cancers” (Gundersen, Delnevo, &  Wackowski, 2009, p. 
553).  
Low socioeconomic status (SES) is another factor that continues to be a significant 
predictor of smoking behavior (Fernander, Resnicow, Viswantath & Perez-Stable, 2011). 
Research findings show that smoking is more prevalent in low SES populations. For people 
living below the poverty level, 28.9% smoke, compared to 18.3% that live at or above the 
poverty level. 
Individuals with a general education degree (GED) versus a high school diploma have 
significantly higher rates of smoking (Fernander, et al., 2011). The smoking rates based on type 
of degree are: 
 About 24 of every 100 adults with 12 or fewer years of education (no diploma) (24.2%) 
(CDC, 2015, paragraph 2) 
 More than 41 of every 100 adults with a general education degree (GED) certificate 
(41.4%) (CDC, 2015, paragraph 2) 
 22 of every 100 adults with a high school diploma (22.0%) (CDC, 2015, paragraph 2)  
In Minnesota, smoking disproportionately impacts people of low socioeconomic status 
(SES). Smoking affects some groups more than others, including those with lower income and 
lower educational achievement (ClearWay Minnesota, 2012, p. 1). These statistics describe the 
negative impact of smoking on underserved populations. For this reason, it is crucial to identify 









Many programs have been developed to address smoking cessation, but according to the 
American Cancer Society (ACS), about 42 million (1 out of every 5) adults in the United States 
currently smoke. Only about 4% to 7% of people are able to quit on any given attempt without 
medications or other help (ACS, 2014). Due to the negative health effects of tobacco, it is 
important to identify the most effective strategies to address both the physical and behavioral 
aspects of nicotine dependence to support smoking abstinence.  
Purpose 
Quitting tobacco has many challenges and it is often difficult for people to quit. It is not 
uncommon for some people to attempt standard smoking cessation treatments and continue to 
smoke. Frequent relapses from tobacco can lead to a sense of failure and belief they can never 
stop tobacco. The purpose of this project was to identify and evaluate new strategies that can be 
added to a traditional smoking cessation program to increase smoking cessation rates in an adult 
outpatient population.  
Objectives 
The main objective for this project was to identify new strategies that can be added to a 
traditional smoking cessation program to improve smoking abstinence rates in an adult outpatient 
clinic. This process began with a literature search to identify best practices to address smoking 
cessation and behavioral patterns that influence a person’s ability to quit smoking. The goal was 
to identify new strategies to support smoking cessation. A feasibility study of pre- post-test 
design was created to evaluate the impact of these new strategies on smoking quit rates in an 
adult outpatient clinic. 
 
 




 The Centers for Medicare and Medicaid Services (CMS) have mandated a reduction in 
payments to hospitals with excessive readmission rates.  At the site of this systems change 
project, hospital readmission data were collected for one year; the data were reviewed and 
patterns identified. Smoking was identified as a contributing factor toward higher readmissions 
rates. As a result, tobacco cessation became a part of the strategic plan, and a role became 
available for the researcher to develop an outpatient smoking cessation program.  
Challenges 
The challenges for this study were related to the nature of smoking cessation in and of 
itself. Research findings illustrate that quitting smoking is difficult and often leads to relapse and 
continued use of tobacco. It was hypothesized that it may be difficult to recruit and retain 
participants for this project. Recruitment can be slow at onset with the development of any new 
program. Limited referrals would affect the generalizability of this study due to small sample 
size.  
Summary 
 Nicotine found in tobacco is a highly addictive substance making it difficult for users to 
quit. Though the incidence of smoking is decreasing among adults, disparities exist when 
evaluated by race, education, and socioeconomic status. The health of individuals who continue 
to use tobacco can be negatively impacted resulting in frequent visits to the hospital. To reduce 
smoking prevalence, it is necessary to identify specific factors that interfere with successful 
smoking abstinence and create new strategies to address those factors. This project focused on 
identifying new strategies that can increase a person’s level of confidence and belief they can 
truly quit smoking to positively impact smoking cessation rates. 
 





The researcher used two theories to create the theoretical framework for this project: the 
Social Cognitive Theory (SCT) by Albert Bandura (Bandura, 1977) and the Transtheoretical 
Model of Change (TTM) by James Prochaska (Prochaska & De Clemente, 1983). These two 
theories describe the influence of self-efficacy on behavior change and how behavior change 
occurs. 
Social Cognitive Theory 
Psychologist Albert Bandura (1977) created a theoretical framework called Social 
Cognitive Theory which explains how a person’s degree of self-efficacy (or belief they can make 
a behavior change) is influenced by observational learning and social experiences. Self-efficacy 
is at the center of Social Cognitive Theory. There are four major psychological processes that 
influence self-efficacy and affect human functioning. These processes are: 
1. Cognitive Processes: A person’s belief shapes their self-efficacy 
2. Motivational Processes: People form beliefs of what they can do. Self-efficacy plays a 
role in motivation. 
3. Affective Processes: Self-efficacy is the ability to exercise control over stressors. The 
inability to exercise control can result in anxiety and depression. 
4. Selection Processes: The development of self-efficacy related processes influences a 
person’s ability to exercise control over day to day stressors (Bandura, 1994). 
The most effective way to acquire a strong sense of self-efficacy is by mastery of experiences. 
To increase a person’s ability to exercise influence over created goals requires structuring ways 
to build coping skills and instill beliefs the goals can be achieved.  This ability to exercise self-
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influence provides a major cognitive mechanism for motivation. People often rely on their 
emotional and somatic states when judging their capabilities. They often interpret tension and 
anxiety as a sign they can’t complete the task. A positive mood is associated with a higher 
perceived self-efficacy; a negative mood decreases it. Providing a way to reduce tension and 
stress can help to increase self-efficacy (Bandura, 1994). 
 Bandura described four main sources that influence the development and maintenance of 
a person’s self-efficacy: performance accomplishments or mastery experiences, vicarious 
experiences, verbal or social persuasion, and physiological, or somatic and emotional states. 
Individuals with higher levels of self-efficacy believe that they have the capability to exert 
control over stressful situations and can: 
1. Approach difficult tasks as challenges to be mastered; 
2. Set challenging goals and maintain strong commitment to them; 
3. Heighten or sustain their efforts in the face of failures or setbacks; 
4. Attribute failure to insufficient effort or deficient knowledge and skills which are 
acquirable; and 
5. Approach threatening situations with the assurance they can exercise control over 
them.  
An increased sense of control can be achieved by modeling the behavior of others and gaining 
confidence. (Bandura, 1994, p. 2). 
Several studies have examined the relationship between self-efficacy and smoking 
cessation. Mudde, Kok, and Strecher (1989) found that efficacy beliefs increased after treatment, 
and those who had acquired the highest levels of self-efficacy remained successful quitters as 
assessed in a one-year period.   
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Transtheoretical Model of Change 
 The Transtheoretical Model of Change (TTM) is an integrative model of behavior change 
developed by Prochaska & DiClemente (1983). Health professionals have used the TTM to 
develop effective interventions to promote health behavior change. This model focuses on the 
decision making of an individual based on the influence of various emotions, cognitions, and 
behavior.  The TTM model describes how people can modify an unhealthy behavior to acquire a 
new, healthier behavior. There are five stages of change in this model, and they include:  
1. Precontemplation; Patient does not plan to take action with behavior change. 
2. Contemplation: Patient is weighing the pros and cons of behavior change. 
3. Preparation: Patient has decided to make a behavior change. 
4. Action: Patient has a plan in place and is working toward the behavior change. 
5. Maintenance: Patient has successfully achieved the behavior change and is working on 
preventing relapse (Velicer, Prochaska, Fava, Norman & Redding, 1998). 
The core components of this model are the process of change, decisional balance, self-efficacy, 
and temptation.  Decisional balance is a key component of behavior change. It reflects the 
individual’s relative weighing of the pros and cons of making a change. Tied into this process is 
self-efficacy, having the confidence to cope with high-risk situations without relapse. The 
Situational Temptation Measure reflects the intensity of urges to engage in a specific behavior 
when in the midst of a difficult situation. Self-efficacy plays a key role providing confidence not 
to engage in a specific behavior like smoking. Measuring self-efficacy and situational temptation 
can help to predict which individuals are likely to relapse (Velicer, et al., 1998). The TTM model 
can be utilized at the individual level or in a population setting. 
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 These two theories were used to guide this project focusing on identifying strategies to 
increase confidence and self-efficacy that could be added to a traditional smoking cessation 
program with the goal of shifting the decisional balance toward quitting smoking. 
Ethics and Social Justice 
The ethical framework selected to support this program was derived from the American 
Nurses Association’s document Nursing’s Social Policy Statement: The Essence of the 
Profession (ANA, 2010). This framework outlines nursing’s relationship with society and 
nursing’s obligation to those who receive nursing care. One of the social concerns stated in the 
policy statement is: 
Quality health care is a human right for all. To improve the quality of care, healthcare 
professionals must address these complex issues: increasing costs of care; health 
disparities; and the lack of safe, accessible, and available healthcare services and 
resources. (ANA, 2010, p. 8).  
Nursing interventions “are intended to produce beneficial effects for the patient, family, or 
community” (ANA, 2010, p. 13).  Strategies identified to increase the potential for an individual 
to exert control over their level of motivation and stop using tobacco would be a nursing 
intervention that benefits the patient, family, and community. 
According to the Catechism of the Catholic Church (1994), Catholic Social Teaching 
supports putting the needs of the poor and vulnerable first. If socioeconomic deprivations 
increase the likelihood to use tobacco, individuals with low SES are at greater risk for death and 








The researcher conducted a database search to secure peer-reviewed research for best 
practices for smoking cessation. Databases examined included Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), PubMed, Medline, and the Cochrane Database of 
Systematic Reviews (CDSR).  Key words for the search included best practices for smoking 
cessation, advanced practice nurse, self-efficacy, health coaching and motivational interviewing. 
Search parameters included articles from the last five years and English language journals only.  
The researcher identified and reviewed government websites that provide policy and health 
information that were identified through this search. 
Research Themes 
The search yielded two main themes for best practices to address smoking cessation: the 
use of medications and behavioral interventions. The topic of behavioral change included the use 
of motivational interviewing, health coaching, and high levels of self-efficacy to influence 
motivation. 
Critical Analysis of Evidence Related to the Clinical Question 
The clinical question for this study was “How does the implementation of strategies 
designed to increase a person’s degree of self-efficacy impact smoking cessation rates in adult 
outpatient population when compared to traditional methods? There was extensive evidence in 
the literature to support smoking cessation, but not all evidence was equally valid, reliable, and 
relevant.  The literature search yielded nine articles, one set of clinical practice guidelines, and 
one meta-analysis related to smoking cessation medications. Individual studies will be reviewed 
first, followed by the review of the clinical practice guidelines and meta-analysis. 
 
 




Medications.  Three studies (Dezee, Wink, & Cowan, 2013; Kotz, Brown, & West, 
2013; Kralikova, Kmetova, Stepankova, Zvolska, Davis, & West, 2013) discussed combining 
medications and behavioral interventions to support smoking cessation.   Dezee et al. (2013) 
acknowledged that the best practices for smoking cessation were the combination of counseling 
and medications. The aim of their study was to compare the effectiveness of internet-based 
tobacco counseling versus in-person counseling and taking Varenicline. The investigators 
conducted a randomized control trial in a military medical setting of patients in the active phase 
of quitting. Quit rates were defined as abstinence at 12 weeks and confirmed by exhaled carbon 
monoxide testing. The findings revealed a 43% completion rate at 12 weeks; internet-based 
counseling was 21% (36/173) and in-person counseling 18% (8/44), p=0.7. Similar quit rates 
between the two groups suggested that internet counseling may be equivalent to in-person 
counseling and medication. 
 The strength of this study was a study design appropriate for the clinical question.  
Weaknesses of this study were methodology and data analysis.  The study was terminated early 
due to concerns about new information and potential side effects of Varenicline.  The original 
enrollment was set at 600 which would provide a statistical power of 99%.  In-person counseling 
sessions were limited in number, so equal randomization to study groups could not occur.  The 
number who completed the study were not similar: in-person counseling group: n=8 (18%) and 
Internet group: n=36 (21%).  There was the potential for bias with uneven assignment into 
groups.  Therefore, the validity of this study is reduced because of small completion rate and 
potential for bias.  These factors could result in a Type II error to find a difference when one 
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exists.  Most significant was a reported p-value of 0.7 which is statistically insignificant to 
establish a true difference in the populations. 
Kotz et al. (2103) conducted a study to compare two medications often prescribed for 
smoking cessation in a clinic setting and available over the counter for the general population. 
The different treatments included the use of prescription medication for smoking cessation 
combined with behavioral support by a health professional, or an individual buying nicotine 
replacement therapies over the counter, not supported by behavioral support. The two 
medications compared were Varenicline and Nicotine replacement therapies (NRT). The design 
included a prospective cohort study of 270 adults participating in a household survey who 
smoked at baseline and had their smoking status assessed at six-months. The aim was to look for 
an association between smoking abstinence and use of different smoking cessation treatments. 
The Fagerstrom questionnaire, a common instrument to determine nicotine dependence, was 
completed by each participant. Variables measured had a potential relationship with smoking 
cessation.  The number of quit attempts, along with demographic characteristics were evaluated 
by statistical analysis.  Findings noted were an adjusted odds ratio of non-smoking in users of 
Varenicline that were 3.83 times higher (95% CI=1.88-7.7) compared to users of the NRT group.  
One strength of this study was a sample size large enough to determine an adequate 
power level. A large sample size allowed for an increased confidence level to assess the 
effectiveness of medications for smoking cessation combined with behavioral support in 
comparison with unaided quitting. Participants provided a self-report of days smoking and quit 
attempts over a six-month period which resulted in problems with recall bias. Though this article 
had some weakness, the primary outcomes were addressed.  Better outcomes were achieved 
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when prescription medications were used in combination with behavior support by health 
professionals, when compared to nicotine replacement therapy (NRT) bought over the counter.  
Kralikova et al. (2013) completed a 52-week study that measured abstinence rates of 
smokers being treated with Varenicline versus NRT.  The study design was a prospective cohort 
of 855 smokers in a smoking cessation clinic.  All patients received behavioral interventions but 
made a choice of whether to use NRT (n=336) or Varenicline (n=519). Abstinence from tobacco 
was determined by carbon monoxide in expired air. The 52-week abstinence rates were 42.8% 
versus 31.0% in those using Varenicline versus NRT, respectively (p<0.001). After adjusting for 
all baseline smoking characteristics variables, the odds of remaining abstinent for 52 weeks was 
2.03 (95% CI: 1.46-2.82) in favor of Varenicline over NRT.  
Strengths of the Kralikova et al. (2013) study included a study design appropriate for the 
clinical questions and a good sample size. Statistical significance was secured using appropriate 
statistical measures with a p-value less than the significance level. 
Weakness of the Kralikova et al. (2013) study included a risk of bias because patients 
were able to choose their own medications.  Choosing one’s own medication is a confounding 
variable that could result in a Type II error. Patients receiving inaccurate instructions on how to 
perform the expired carbon monoxide testing could impact results too.  
Behavioral interventions. Two studies (Smit, Evers, De Vries, & Hoving, 2013; 
Vidrine, Shete, Cao, Greisinger, Harmonson, Sharp, … & Wetter, 2013) assessed different 
components of behavioral interventions to support smoking cessation.  Smit et al. (2013) 
assessed the effectiveness and cost utility of using an internet-based tailored computer program 
and counseling by nursing and compared it to care as usual.  Inclusion and exclusion criteria 
determined the sample size of 414 eligible smokers.  A randomized control trial was conducted, 
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dividing smokers to one of three groups.  The three groups included of smokers who:  received 
multiple tailoring and counseling (n=163), multiple tailoring only (n=132) and usual care 
(n=119). A self-report of quality of life and cost data was provided at 12 months. Participants 
received a monetary payment for completion of the online questionnaires to assess smoking 
status.  Tobacco dependence was determined by the completion of the Fagerstrom questionnaire.  
A weakness of this study was the use of self-report to acquire information which can 
affect validity because no standard categories for responses were provided. Missing data were 
documented.  High dropout rates impacted power analysis.  Attrition led to skewed 
randomization into the intervention groups at baseline.  Monetary benefit for participants can 
create bias and affect validity of the results.  Outcome results varied based on what intervention 
was being considered.  When quality of life was considered, care as usual was identified as 
higher.  The internet–based tailored computer program was more cost effective in supporting 
smoking abstinence.  These study weaknesses limit its value and applicability of results. 
When addressing smoking status at a clinic appointment, Vidrine et al. (2013) tested a 
new behavioral intervention approach.  Ask-Advise-Connect (AAC) was designed to address 
barriers to linking smokers with treatment.  The study design was a randomized control method 
with two treatment arms involving ten family practice clinics in a metropolitan area. Patients 
from five clinics were randomly assigned to the AAC intervention and patients from the other 
five clinics were randomly assigned to or the Ask-Advise-Refer (AAR).  The AAC group 
(n=2052) was linked to a quitline at the time of the appointment. In the AAR clinic (n=1611), 
smokers were given information and told to call a quitline on their own.  The data were analyzed 
using p-values and odds ratio statistics.  A 13-fold increase in the proportion of smokers 
enrolling in treatment was higher in the ACC group. This evidence supports the benefit of 
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directing patients to a quitline to support smoking cessation.  The design was a strength of the 
study because the main outcome was to measure the treatment results between groups.  Validity 
of the results was supported by a p<0.001 for the ACC results which was statistically significant.  
Results of this study are positive and would be applicable to clinical practice. 
Nurse as an Educator 
Patient education is an essential nursing intervention.  A group of researchers (Chan, 
Jayasinghe, Christi, Laws, Orr, Williams, … & Harris, 2013) evaluated the health outcomes of 
patients instructed to improve their health by participating in behavior change.    Their study was 
a quasi-experimental design with one group receiving instruction from generalist nurses (n=129) 
and the other group being a control.  Nurses supporting the intervention group received 
education by participating in interviews and focus groups designed to facilitate changes in their 
practice.  The practice changes included incorporating service level interventions, such as patient 
assessment and brief interventions to support healthy lifestyle changes in their care of patients.  
Patients were randomly selected and placed into either an intervention group (nurses received 
training) or a control group (usual care).  Lifestyle risk factor management was collected by self-
report via an on-line survey.  A score was calculated for each risk factor by totaling scores.  
ANOVA analysis was used to assess the differences between the groups. Outcomes were 
improved when nurses provided education on each behavioral change topic. 
The researchers provided a list that fully explained the utilized interventions which was 
the strength of the study.  Another strength was the chosen interventions were associated with 
positive impact on lifestyle changes in patients, the goal of this study. A quasi-experimental 
study is less rigorous than a random control trial.  A major weakness of the study was a low 
overall response rate of 54/129 which affects generalizability.  The survey included a 7-point 
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Likert scale which was pilot tested before it was distributed.  Though findings by a self-report 
may be biased, the use of a pilot study helps to increase clarity by testing for discrepancy of 
survey responses. 
 Results suggest that nurse’s education on lifestyle management can influence the health 
outcomes of their patients.  Though weaknesses exist in this study, the nurse’s education of 
patients was an important part of behavior change.  
Providing an intervention is not the only strategy for promoting behavior change.  Each 
individual has unique characteristics and this may have an influence on outcomes.  The ability of 
each individual to be motivated and believe change can happen often varies.  Boogar and 
Mirkouhi (2013) studied self-efficacy and mindfulness to understand how they may influence 
smoking cessation rates.  The researchers conducted a descriptive study on a convenience sample 
of 284 people who were attending ten smoking cessation clinics in Tehran.  All participants 
completed the Smoking Self-Efficacy Questionnaire (SEQ-12).  The main variables that 
predicted smoking cessation were self-efficacy (OR=9.81; CI: 3.12-17.28%) and mindfulness 
(OR=5.66; CI: 1.226-11.258%).  Rigor was supported by ongoing evaluation of the SEQ-12.  No 
established reliability was reported for the questionnaire.  A strength of this study was that the 
research results supported an intuitive concept, that higher degrees of self-efficacy may improve 
smoking cessation outcomes.  A convenience sample likely reduces generalizability because 
results in the sample may not be representative of the population.  Researchers concluded that 
promotion of self-efficacy could be used as a therapeutic intervention for smokers.  This 
information may be applicable to clinical practice but should be researched under a more 
rigorous study design.  
 
 




The researcher identified two additional articles that found a relationship between 
increased self-efficacy and smoking cessation rates. Jardin and Carpenter (2012) identified 849 
smokers not interested in quitting tobacco who were already participating in a randomized 
controlled trial to promote tobacco quit attempts and cessation.  While this study was built on 
existing literature about this topic, most studies defined a quit attempt as lasting at least one day. 
To reduce bias, it is important to examine both self-defined quit attempts and 24-hour quit 
attempts. Participants were recruited proactively through a national market research firm. One of 
the inclusion criteria was being a current cigarette smoker of greater than ten cigarettes per day. 
Upon receipt of a consent and baseline questionnaire, participants were randomly placed into one 
of two intervention groups: practice quitting attempts (PQA) through a behavioral exercise or 
PQA combined with Nicotine Replacement Therapies (NRT). The study findings confirmed that 
for smokers not currently interested in quitting, self-efficacy and motivation were key factors in 
the cessation process. Several measures were evaluated through a multivariate logistics 
approach. Among all the variables analyzed, self-efficacy emerged as the only variable 
consistently linked with all outcomes examined. NRT has been reported to increase a person’s 
self-efficacy by reducing withdrawal and cravings, increasing one’s sense of self-control over 
tobacco. In addition, placing the focus around motivational interventions can support quit 
attempts through confidence building activities and refraining from smoking. Limitations of the 
study were reliance of self-report of smoking status and recall regarding past quit history which 
can both result in bias. The study group was homogeneous as 87% were Caucasian. This 
composition does not address the influence of cultural differences of a heterogeneous sample.   
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In their research, Perkins, Parzynski, Mercincavage, Conklin, and Fonte (2012) studied 
the influence of self-efficacy on behavior change and smoking cessation. Two studies were 
simultaneously followed: study one lasted four weeks, and study two lasted six weeks. Study one 
included the use of the nicotine patch and a placebo nicotine patch. Study two studied the use of 
Varenicline and a placebo. A one-item self-efficacy scale was created. Patients in both groups 
were asked to respond to the self-efficacy measure the next day and at one week. Study group 
two required additional time due to the requirement of tapering up the dose of Varenicline. The 
one-item self-efficacy measure asked was, “I am confident I will not smoke at all tomorrow.” 
The measure was rated on a 1 to 100 scale. (“1” represented “not at all” and “100” represented 
“extremely”). To identify if self-efficacy predicted the likelihood of not smoking the follow day, 
the transition from baseline to post-treatment was examined. The results showed that a higher 
rating of self-efficacy predicted next day’s abstinence in both studies. For every 10-point 
increase in self-efficacy, the next day abstinence report increased by 0.287 (Odds Ratio: 1.33) in 
the patch study and by 0.262 (Odds ratio: 1.29) in the Varenicline study. The findings support 
that self-efficacy can be used as a predictor for smoking abstinence and may influence 
subsequent smoking behavior change. A limitation of this study was the reliance on self-report. 
Motivational Interviewing 
Motivational interviewing (MI) is another behavioral intervention that shows promise in 
improving smoking cessation outcomes.  MI is a communication tool used by a health coach or 
health care provider to help patients identify ambivalence with making a behavior change and 
provide support to identify self-motivation.  Researchers (Lindqvist, Forsberg, Rosendahl, 
Enenbringk, & Helgason, 2013) stated that MI appears to increase the effectiveness of smoking 
cessation counseling when integrated into standard treatment.  When MI and Cognitive 
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Behavioral Therapy (CBT) were integrated into smoking cessation counseling, six-month 
continuous abstinence rates increased by 5% (Lindqvist et al., 2013). Lindqvist et al. used a 
randomized control design along with a sample size of n=772 which created a high-quality study.  
The interventions, outcomes, and statistics were applicable to the clinical question.  Results 
illustrated a meaningful association between motivational interviewing and smoking cessation.  
A statistically significant result (p=0.047 ) indicates a likely link between increased self-efficacy 
and smoking cessation for continuous abstinence at six months for patients receiving 
motivational interviewing.  Motivational interviewing can positively influence self-efficacy, so 
could adding motivational interviewing be the key to assist patients unable to quit?  Further 
study is needed to determine the influence of motivational interviewing and an increased sense of 
self-efficacy on smoking cessation outcomes. 
National Practice Guideline Review 
The researcher conducted a database search to identify clinical practice guidelines that 
could provide recommendations to address smoking cessation in clinical practice.  A systematic 
review resulted in the identification of the Clinical Practice Guidelines: Treating Tobacco Use 
and Dependence: 2008 Update (Fiore, Jaen, Baker, Baily, Benowitz, ...& Wewers, 2008).  The 
Cochrane Review rated the quality of the evidence as high (Fiore et al., 2008).  The study design 
supported the highest quality evidence completed by a systematic review and meta-analysis of 11 
specific topics.  A thorough database search was completed and relevant studies were unlikely 
missed. A detailed analysis was completed by a panel of experts knowledgeable in this area, 
based on clinical experience and expert opinion. Strong evidence was available to support using 
the 2008 Clinical Practice Guidelines in clinical practice.  The purpose statement was clearly 
stated.  Appropriate inclusion/exclusion criteria were provided.  An Agree II tool was used to 
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appraise the guidelines.  An evaluation of six domains resulted in the highest possible scores. 
Evidence and statistical significance were provided for each recommendation.   The guidelines 
are reviewed regularly and updates are provided.  These guidelines provide a robust review of 
the evidence and valid recommendations available for clinical providers to use in practice. The 
overall rating of these guidelines was seven, the highest possible level of quality.   
Meta-Analysis Review 
  The researcher searched the Cochrane Database of Systematic Reviews (CDSR, 2014) to 
identify pharmacological interventions for smoking cessation.  This search yielded a study by 
Cahill, Stevens, Perera, and Lancaster (2013) that identified 12 treatment-specific reviews.  The 
analysis covered 267 studies, involving 101,804 participants.  These reviews were conducted 
between 2008 and 2012 and all studies were random control trials.  An AMSTAR tool was used 
to assess the quality of the systematic reviews.  Nine domains were addressed against nine 
different smoking cessation medications.  Characteristics of the included reviews compared 
interventions (one specific smoking cessation medication) against a comparison (either placebo 
or a different smoking cessation medication).  Outcomes were measured at six months or 12 
months.  Limitations were reported as obtaining information from abstracts of four Level B 
trials; a lower quality trial.  Most trials did not report methods in enough detail to assess the 
quality of randomization. 
Summary 
Researchers identified that smoking cessation in the population is best addressed by the 
use of medications and behavioral interventions. Evidenced-based practice guidelines are 
available to help guide practice. In several studies, smoking cessation outcomes were improved 
with the use of Varenicline.  However, since each patient has unique issues and characteristics, 
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an individualized treatment plan is recommended.  There are many variables that can affect 
positive outcomes. Access to a medical provider or simply a lack of time may require the use of 
an online program over a face-to-face appointment with a clinic provider. In the literature, best 
practices for smoking cessation include the use of evidence-based practice guidelines to support 
smoking cessation. Since a link has been found between high levels of self-efficacy and 
increased smoking cessation rates, and MI is effective with working through ambivalence to 
make a behavior change, a combination of all three approaches may provide the answer. Further 
study is recommended to explore this relationship. 
Level and Quality of the Evidence 
The research question addressed in this paper explored the relationship between strategies 
designed to increase a person’s degree of self-efficacy and the impact on smoking cessation 
rates.  All research reviewed for this project was ranked and assigned a level of evidence (see 
Appendix A for descriptions of levels of evidence) and a quality rating (See Appendix B for 
grades of recommendations). Vidrine et al. (2013) was rated as a Level Five, Quality A, or 
highest quality. Five studies are rated Quality B or good quality (Chan et al, 2013; Dezee et al., 
2013; Kotz et al., 2013; Kralikova et al., 2013; and Lindquist et al., 2013); two studies are rated 
Quality C or low quality (Boogar & Mirkouhi, 2013; Smit et al., 2013). One study was rated as a 
Quality D or low quality study (Perkins et al., 2012). However, robust recommendations were 
provided by the 2008 Clinical Practice Guidelines.  The Grading of Recommendations 
Assessment, Development and Evaluation (GRADE) scale was used to determine the strength of 
evidence. The GRADE scale assigned to the 2008 Clinical Practice Guidelines was Code A, 
indicating the quality of evidence was high.  
 
 




There is a large body of evidence in the literature to support smoking cessation.  The 
findings indicated that smoking abstinence was best achieved by a combination of medications 
and behavioral interventions.  The gold standard for smoking cessation information was Clinical 
Practice Guidelines: Treating Tobacco Use and Dependence: 2008 Update (Fiore et al., 2008).  
These guidelines have been rigorously evaluated and have been proven to be safe and effective.  
These guidelines have been adopted by practitioners yielding positive practice changes.  Medical 
providers can combine the information in the guidelines with their clinical judgment to 
individualize care for each patient.  Best practice recommendations resulted in clinical practice 
guidelines that are valid and backed by physician leaders and validated by the Agency for 
Research and Healthcare Quality (AHRQ).  While these guidelines are available and used, gaps 
still exist in regards to positive or permanent behavior change because people are still smoking. 
Summary of Recommendations 
Many smokers find it hard to quit because nicotine is addictive. For people ready to quit, 
a discussion with their health care provider may provide direction and support.  To provide safe 
and effective care for each patient, identification of best practices that are valid can help to guide 
care.  The 2008 Clinical Practice Guidelines: Tobacco Use and Dependence (Fiore et al. 2008) 
were often referenced as the primary source of evidence for smoking cessation.  Quitting tobacco 
has many challenges and is best addressed by the combination of medications and behavioral 
modification to support tobacco abstinence. Health care providers play a major keep role in 
promoting healthy behaviors and supporting behavior change, but some lack the appropriate 
education and training. Patient education is an essential nursing intervention which can influence 
patients’ movement toward behavior change. Health care providers need knowledge to begin the 
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dialogue of change talk with their patients. Health coaching and motivational interviewing are 
two options to educate health care providers about initiating effective change talk. 
  
 




Project Design and Research Methodology  
Initially, this project was designed to be a quasi-experimental study; it became evident 
during the recruitment process that a feasibility study would be the appropriate first step. . 
Specific Aims of the Proposed Research 
In the literature, perceived self-efficacy is closely related with behavioral intentions and 
health behavior change. The aim of this project was to evaluate the effectiveness of strategies 
designed to increase self-efficacy on smoking cessation rates. A feasibility study was designed to 
assess the effectiveness of strategies to increase self-efficacy and to assess their influence on 
smoking cessation rates. 
Two outcomes were measured: 
 A decrease or four-month point prevalence abstinence of tobacco  
 Influence of self-efficacy strategies on smoking cessation rates 
The self-efficacy promoting strategies used in this study included: 
1. Motivational Interviewing by an advanced practice nurse who was a Certified Health 
and Wellness Coach and skilled at Motivational Interviewing. 
2. Creation of short-term, achievable goals with the patient to develop confidence; 
success with minimal effort reinforces a strong sense of self-efficacy (Bandura, 
1977). 
3. Implementation of Bandura’s two-step approach (Strecher, DeVellis, Becker, & 
Rosenstuck, 1986) 
o Ask patient if particular behavior can be accomplished,  
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o  For each task have them rate the strength of his/her belief to accomplish the 
task. 
Study Instruments  
Three instruments were employed to collect data for this project.  
Smoking self-efficacy questionnaire [SEQ-12] (Appendix C). The SEQ-12 is a 12-item 
scale which measures the confidence to refrain from smoking when faced with internal stimuli 
(like depression) and external stimuli (like being exposed to other smokers). The SEQ-12 was 
designed to measure the confidence of current and former smokers in their ability to abstain from 
smoking in high-risk situation. Etter, Gergman, Humair, and Perneger (2000) developed the 
SEQ-12 and have documented validity and reliability for this tool. “SEQ-12 fulfilled criteria of 
content, construct, and predictive validity, was highly reliable in test-retest procedures, had 
sound factorial structure, high internal consistency and not biased by social desirability” (Etter et 
al., 2000, p. 2). 
Fagerstrom questionnaire (Appendix D). This tool is an eight-item questionnaire  
commonly used to estimate the degree of nicotine dependence in tobacco smoking that is often 
used in smoking cessation research. 
Readiness to change scale (Appendix E). This scale helps to identify readiness for 
behavior change by ranking importance and confidence for behavior change on a 10-item scale 
(“1” = “not important or confident” and “10” = “very important or confident”). 
Subject Selection 
Participants were recruited by two methods: self-referred or provider referred. All 
patients were provided information about the study at the time of their scheduled appointment in 
the existing smoking cessation program at the site of the study. 
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Participants were required to be 18 years of age or older. Pregnant and breast feeding 
women were excluded from this study due to the extra inconvenience of meeting the study 
requirements.  
Study Procedures 
Enrollment. A pre- post-test design and consecutive enrollment of participants to groups 
was utilized.  All patients referred to the existing smoking cessation program at the site of the 
study were invited to participate.  The study was introduced to the participant by an Advanced 
Practice Registered Nurse (APRN) who provided an opportunity to ask questions. The enlistment 
process met strict guidelines outlined by the site’s Institutional Review Board (IRB) process and 
Health Insurance Portability and Accountability Act (HIPAA) guidelines. If the patient decided 
to participate, they signed an IRB approved consent form and were provided a signed copy. 
Study process. Participants were consecutively enrolled into one of two groups. The first 
five participants received standard care from the current smoking cessation program and were 
identified as Group A (control group), and the next five participants received the current 
smoking program protocol plus additional strategies designed to support smoking cessation and 
were identified as Group B (intervention group) 
Group A. Each patient had an individualized care plan created by the patient and 
advanced practice nurse as per the protocol for the smoking cessation program at the site facility. 
Components of the program can include: 
 Care as usual; this care will not be influenced by the study procedures 
 Physical exam and review of medical records  
 Drug therapy 
 Counseling or coaching 
 





 Stress management programs or tools 
 Craving to Quit application 
Group B. Includes regular care stated above plus the following: 
 Provide strategies designed to increase self-efficacy, 
 Use motivational interviewing.  The advanced practice nurse used motivational 
interviewing skills learned in a program to be a Certified Health and Wellness Coach 
through Wellcoaches, Inc. The motivational skills are individualized for each participant 
based on the responses or feedback provided by the participant. Sample questions help to 
define motivational interviewing, as developed by Miller and Rollnick (2002), and are as 
follows (as cited in Moore, 2004): 
1. What do you want to know about quitting smoking? 
2. Do you want to set up some goals today? 
3. What small steps can you take to make that change? How often? When? 
4. How do you want to get here? 
5. What is your goal for today?  
6. What do you want? 
7. How can you change that? 
 Create short-term, achievable goals to develop confidence; success with minimal effort 
reinforces a strong sense of self-efficacy 
 Implement Bandura’s two-step approach 
1.  Ask the patient if particular behavior can be accomplished.  
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2. For each task have them rate the strength of his/her belief to accomplish task. 
Definition of motivational interviewing. Miller and Rollnick (2002) define motivational 
interviewing as is a counseling methodology developed over the past 15 years in the addiction 
treatment field. MI is defined as a client-centered, directive method for enhancing intrinsic 
motivation to change by exploring and resolving ambivalence. This methodology considers what 
is necessary to initiate and support change-summarized briefly as being ready, willing and able-
and uses a decisional balance sheet to consider the pros and cons of the status quo and change 
under consideration. Though a careful balance of inquiry and reflective listening, interviewers 
elicit and selectively reinforce pro-change talk, and respond to resistance in a way that is 
intended to diminish it (as cited in Moore, 2004). 
The Advanced Practice Registered Nurse reviewed the medical record and conducted a 
physical examination for all enrollees. Review of this information is part of the routine visit for a 
patient/employee with the APRN for purposes of individualizing treatment. Information gained 
in the physical exam and medical record review was not included in the write up for this study. 
Each participant was asked to complete four sessions. The first session was one hour; the 
next three sessions were 30-minute sessions scheduled at four weeks, eight weeks, 12 weeks and 
four months. Each participant was scheduled to complete three brief questionnaires at their first 
visit and at the 12 weeks visit. The three questionnaires were the Fagerstrom, the SEQ-12, and 
the Readiness to Change Scale. Each participant was told they would be contacted at four months 
by phone or email to provide a verbal response of their smoking status, whether a total cessation 








The risks for this study were limited. It was acknowledged that quitting smoking can be 
stressful for some patients and will vary from person to person, and this is related to weaning off 
nicotine. Therefore, a stressful response would likely happen regardless of participating in this 
study. When comparing the control and intervention groups, the effects of stress would be the 
same. There were no additional risks from engaging in motivational interviewing and strategies 
to increase self-efficacy.  
Pre- and post-test studies using consecutive enrollment facilitate comparison of the 
effects of additional interventions to intervention group with usual care provided to control 
group. All participants received the current usual care. Also, the protocol had been designed to 
not over burden participants. The intervention was evidence-based to assure safety.   
Monitoring and Reporting of Adverse Events 
Continuous monitoring for adverse events (AE) was conducted by the APRN at each 
study visit. Adverse events constitute any negative change in health status or any undesirable 
experience associated with the study intervention reported by study participants.  Serious adverse 
events (SAE) include death, disability, emergency evaluation or hospitalization. To maintain 
compliance with IRB standards, negative findings were required to be reported within 10 days. 
No negative findings were identified.  
Statistical Analysis Plan 
A pre- and post-test design was used to compare differences between the two groups. In a 
pre- post-test design all conditions are the same for the control and intervention groups, with the 
exception that the intervention group was exposed to additional intervention strategies, in this 
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study, interventions designed to increase self-efficacy.  The independent variable was self-
efficacy strategies and the dependent variable was smoking cessation. 
The plan for statistical analysis was to compare results from questionnaires that all 
participants completed at baseline and at 12 weeks. The individual change scores for each 
participant would be calculated first and then the change scores would be summed for each 
Group. It was hypothesized that change scores on the SEQ-12 and Readiness to Change scale 
would be larger at 12 weeks and dependence on tobacco (as measured by the Fagerstrom 
Questionnaire), would be smaller at 12 weeks in Group B relative to Group A.  Simple t-tests 
would be used to measure if there was a difference between the two groups on each of the three 
questionnaires.   
Ethical Considerations 
Approval for this study was obtained from on offsite Institutional Review Board (IRB) 
for the organization that was the site of the study. This offsite IRB operates in accordance with 
the ethical principles that have their origin in the Declaration of Helsinki and that are consistent 
with good clinical practice and applicable regulatory requirements.  
Confidentiality 
To provide confidentiality, no names were used on the documents in this study. Each 
participant was assigned a specific code. All documents were kept in locked cabinets only 
accessible to the APRN. Every effort was made to assure the confidentiality of all participants’ 
records in this study.  
Time Frame 
Data were collected from February 2015 to September 2015. Data were analyzed in fall 
2015 and reported in December 2015.  
 




Several studies have examined the relationship between self-efficacy and smoking 
cessation. However, motivational interviewing was identified as a confounding variable which 
can positively influence both the dependent and independent variable. The use of motivational 
interviewing can provide an additional strategy for the APRN to support behavior change in their 
patients.  
 





A feasibility study using a pre- and post-test design was utilized to answer the clinical 
question: How does the implementation of strategies designed to increase a person’s degree of 
self-efficacy impact smoking cessation rates in adult outpatient population when compared to 
traditional methods? A total of ten patients agreed to participate in this feasibility study.  All 
patients were provided with information about the study and offered an opportunity to ask 
questions prior to signing consent to participate. There was no random assignment and therefore 
participants did not have the same chance of being in the control or experimental group.  A cut 
off score was assigned; the first five patients received standardized treatment and the next five 
patients received additional self-efficacy interventions. The goal was to identify whether there 
was increased quit rates in the five patients receiving the treatment; however, only three out of 
the ten patients followed through with the entire study. Due to the high dropout rate, a statistical 
analysis was unable to be completed. Data about participants’ completion of the three 
questionnaires at study intervals are available.  The study intervals were pre-study, 8 weeks and 
12 weeks. The researcher called participants four months after their study date to secure self-









Running head: SELF-EFFICACY 
 
 
Table 1: Documentation of Participants’ Completion of Questionnaires 
________________________________________________________________ 
Participant Pre-Study 8 Weeks 12 Weeks 4 months Quit_ 
SC-A  X      X  X 
SC-B  X  X 
SC-C  X 
SC-D  X  X 
SC-E  X 
SC-F  X  X 
SC-G  X 
SC-H  X 
SC-I  X 
SC-H  X 
SC-I  X 
SC-J  X 
 
Return on Investment 
An added value of this project was a positive return on investment for the organization. 
Data were collected at the study site from April 1, 2013 to March 31, 2014 to evaluate smoking 
status and readmission rates. The Centers for Medicare and Medicaid Services (CMS) have 
mandated that hospitals with unplanned 30-day readmission after a patient is discharged from the 
hospital will not be reimbursed for those services. There were five medical conditions which 
were used to determine 30-day readmission rates. They were anterior myocardial infarction or 
AMI, heart failure or HF, pneumonia, chronic obstructive pulmonary disease or COPD, and 
stroke. The patient populations with AMI, HF, and pneumonia were analyzed in this data 
collection process.  
After evaluating the data, it was determined that smoking is generally a contributing 
factor toward higher readmission rates. Even though the AMI does not follow the pattern 
identified, former smokers did have the highest readmission rate. It is one variable among many 
that helps to indicate a patient is at higher risk for readmission. The categories for Smoking 
 
Running head: SELF-EFFICACY 
 
 
Status are listed as: current every day smoker, current some day smoker, former smoker, never 
assessed, never smoker, passive smoke exposure-never smoker, smoker, and current status 
unknown. The total number of patients identified as either in the current every day smoker 
category or current some day smoker category who had unplanned readmissions 30 days after 
discharged during the evaluation period is displayed in Table 2 
 
Table 2: Smoking Status of Diagnosed Acute Myocardial Infarction, Heart Failure, and 
Pneumonia Patients with Unplanned 30-Day Readmissions, April 1, 2013-March 31, 2014  
 
Diagnosis  Current Every Day Smoker Current Some Day Smoker Total 
AMI    27    4   31 
HF    39    7   46 
Pneumonia   26    4   30 
Total    92    15   107 
 
The total number of AMI, HF and pneumonia patients who were discharged between 
April 1, 2013 and March 31, 2014 who were a current every day smoker or current some day 
smoker is displayed in Table 3.  
Table 3: Total Discharges of Diagnosed Acute Myocardial Infarction, Heart Failure, and 
Pneumonia Patients with Unplanned 30-Day Readmissions, April 1, 2013-March 31, 2014  
 
Diagnosis  Current Every Day Smoker Current Some Day Smoker Total 
AMI    449    43   492 
HF    202    38   240 
Pneumonia   207    15   222 
Total    858    96   954 
 
Tobacco use is the single most preventable cause of death and disease in the United States 
(Clearway Minnesota, 2011). The average quit rate for smokers that don’t use medications or 
counseling is 4-7% (American Cancer Society [ACS], 2014).   In the Minnesota Adult Tobacco 
Survey 2010 Update, the return on investment was higher for employers when a compare and 
contrast was done for managing a single care of heart failure. The cost of treating a single case of 
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heart failure was estimated at $5.23 per member per month [PMPM] (Clearway Minnesota, 
2011). A smoker costs a private employer in the United States an extra $5,816 per year compared 
with a nonsmoker (Egan, 2013). The largest cost, at $3,077 annually, came from taking smoking 
breaks (Egan, 2013).   The second largest cost, $2.056, was related to excess health care 
expenses (Egan, 2013). Smokers typically have more health problems than nonsmokers, 
including heart and lung disease and various cancers (Egan, 2013).  
A return on investment was calculated comparing the cost of adding the strategies 
designed to increase self-efficacy to the existing site program against the costs of a smoker to a 
private employer over one year. The budget for this program is illustrated in Table 4, costs 
avoided in Table 5, and the return on investment in Table 6. The benefit to cost ratio was 
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Table 4: Costs to Implement Smoking Cessation Feasibility Study 
Financial Costs    Estimates for 74 Participants Unless Otherwise 
      Indicated 
Salaries 
 Advanced Practice Nurse   $83,200ª 
 Clinical Assistant (Salary to be  $33,280b 
Divided among several providers  (Salaries will not be included because they 
      aren’t an added expense) 
Variable Costs 
 Cost of paper for patient education  
booklet     $66.60d  
 Cost of ink for printing booklet  $407.89e 
 Cost for IRB submission   $2340 
 Health Journey Stop Smoking 
Meditation CD @ $17.09 each  40 participants x $17.98 = $719.20 
 
Program Marketing Costs   $6 
Office Operations    NA  
 
Total      $3,533,69 
Note.ª $50 per hour includes benefits, eight hours, four days per week seeing patients in clinic, 
$50 x 8=$400 per day, calculate $400 x 4 days x 52 weeks per year. 
b 20 per hour includes benefits, eight hour, four days per week assisting in the clinic, calculate 
$20 x 8=$160 per day. 
d cost of paper : $06 per sheet, each patient booklet is 15 pages, 15 x .06=$.90, $.90 x 74 patients. 
e average cost for an ink cartridge=$60.88, one cartridge will print (HP 121 Tri-color Ink 
Cartridge 165 standard pages (with HP 121 Black Ink Cartridge), can print 11 patient manuals on 
one ink cartridge, will need 9 cartridges x $60.88 each. 
 
Table 5: Costs Avoided Per Year 
Costs of Smoker Total Smokers for 4-7% Will Quit Total Smokers Potentially 
   AMI, HF and  Without Support Impacted by Smoking 
   Pneumonia     Cessation Strategies 
 
$5,816   107   107-5.35=101.65 101.65 x $5,816  
Total         $591,196.40 
Note.*(Egan, 2013) 
 
Running head: SELF-EFFICACY 
 
 
Table 6: Financial Worksheet for the Additional Smoking Cessation Strategies Program for 12 
Months 
Program Total Costs    $47 per person x 101.65 people =$4,777.55 
Costs Avoided    $5,816 x 101.65 = $591,196.40  
Difference     $586,418.85 
Return on Investment    $12,274.48  
Note. Return on Investment (ROI) =total benefits/total costs. Return on Investment (ROI): ROI= 
(total benefits-total costs)/total costs x 100. Project deemed acceptable if benefits are greater 
than costs: Benefit-cost ratio>1, ROI is positive. (Rhoads, [PowerPoint], 2013). 
 
Summary 
Though a causal relationship was established in the literature between increased self-
efficacy and higher rates of smoking cessation; in this study, a threat to internal validity existed 
and impacted the dependent variable.  The threat to internal validity was hypothesized to be a 
social threat; because when social research is conducted in the real-world where people can react 
to not only what affects them but also others around them. Often people smoke to help control 
stress because chemicals released in the brain create an increased sense of well-being. If 
individuals trying to quit smoking enter back into a high risk situation, it is less likely they will 

















 The goal of this study was to identify and evaluate new strategies to add to a traditional 
smoking cessation program to increase smoking cessation rates in an adult outpatient population. 
If the new strategies positively impact smoking cessation rates, they would be applied at the 
inpatient level with the goal of impacting hospital readmission rates. There are many physical 
and psychological influences which can impact cessation. Since there was a causal relationship 
identified between high degrees of self-efficacy and improved smoking cessation rates, a 
feasibility study was created to test this relationship. However, a lack of follow- up by the study 
participants made it impossible to compare the pre and posttest results. 
Recommendations 
The recommendations for future studies are based on lessons learned from this project. 
Recommendations are supported by the two theoretical frameworks which guided this project. 
The theory of self-efficacy by Bandura (1977), describes the importance of having confidence to 
cope with high-risk situations without relapse, and the Stages of Change Theory by Prochaska 
and Diclemente (1983) describes how people modify a problem behavior or acquire a positive 
behavior through the Stages of Change model, occurring over time. A high degree of self-
efficacy helps an individual to progress through the stages with less relapse. The intention of this 
project was to provide the skills and incentives which would increase a person’s level of self-
efficacy in order to support their quit attempt especially in stressful situations. What was learned 
during data collection and patient communication and follow-up was a need for greater rigor.  
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The best way to impact smoking cessation rates per the TTM model is to put more focus on the 
assessments of outcomes.  Interventions can be evaluated in terms of their impact, but having a 
higher recruitment, combined with high efficacy will best impact individuals and populations 
with a behavioral health risk. Three recommendations are posed: 
1. Identify more rigorous guidelines for data collection and patient follow-up. Despite the 
reinforcement of required intervals for subsequent visits, follow-up was poor. It was the 
researcher’s ethical responsibility to approach each participant in non-coercive or 
punitive way; however, building into the study a phrase stating, “We need to identify a 
time that I can call you, one day per month”.  This approach would provide a structure for 
a more rigorous health coaching to identify barriers which limit successful smoking 
abstinence. Further, adding that the researcher would send reminder letter or emails to 
participants who did not complete assessment questionnaires as scheduled. 
2. Put more structure to making behavior change happen. Patients may be unable to sustain 
changes when confronted with life’s challenges if they feel overwhelmed by life’s 
demands. It is crucial to address the cognitive and behavioral processes that lead people 
to smoke. Perhaps these challenges could be addressed more effectively in a group 
setting. Bandura's Social Learning Theory stresses the importance of observational 
learning, imitation and modeling.  Providing a group medical visit or support group to 
address smoking cessation, may help to create a community environment and provides a 
platform for patients to ask questions and learn from one another about their experiences. 
3.  Educate health care providers to initiate change talk with their patients. The TTM 
model states that interventions for smoking cessation should be evaluated in terms of the 
impact on entire populations of individuals with behavioral health risks. The TTM model 
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has the potential to have both a high efficacy and a high recruitment rate, thus impacting 
populations more. Health care providers are important part of behavior change. They 
have the ability to impact populations with behavioral health risks just by creating change 
talk with their patients and supportive interventions. Health care providers can be taught 
how to initiate change talk by watching an educational video. Watching this video could 
be provided by the organization, as part of the yearly education and compliance 
requirements.  Providers will learn how to explore patient values, identify social support 
strategies for obstacles, increase confidence, and put a plan in place for triggers, thereby 
empowering patients to more effectively “self-manage” their health condition. 
Summary 
Nicotine found in tobacco is a highly addictive substance making it difficult for users to 
quit. Identifying the factors that can limit successful smoking abstinence is crucial. Evidence-
based practice guidelines for smoking cessation are available and can help guide practice. In the 
literature, a causal relationship was found between high levels of self-efficacy and improved 
smoking cessation rates. A feasibility study was attempted to test this relationship which 
included health coaching, motivational interviewing and strategies designed to increase a 
patient’s degree of self–efficacy, however, due to lack of follow-up by study participants the 
results were unavailable. In regards to future studies in this area, the positive influence of 
motivational interviewing and self-efficacy on each other has been identified. The advanced 
practice nurse can use this knowledge to help support behavior change in their patients. Since 
behavior change occurs over time, establishing more rigorous methods for patient accountability 
and follow-up is recommended.  Patient accountability may be influenced in a positive way if 
change talk begins with their medical provider. Educational videos containing information about 
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how to initiate change talk can provide the education for medical providers in need of knowledge 
to begin this process with their patients, encouraging them to stay engaged and prevent relapse.  
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Levels of Evidence 
Levels of Evidence  
Level 1 - Systematic review & meta-analysis of randomized controlled trials; clinical guidelines 
based on systematic reviews or meta-analyses 
Level 2 - One or more randomized controlled trials 
Level 3 - Controlled trial (no randomization) 
Level 4 - Case-control or cohort study 
Level 5 - Systematic review of descriptive & qualitative studies 
Level 6 - Single descriptive or qualitative study 
Level 7 - Expert opinion 
 
Note: Melnyk, B.M. & Fineout-Overholt, E. (2011). Evidence-based practice in nursing and 
healthcare: A guide to best practice. Philadelphia: Lippincott, Williams & Wilkins. 
  
 




Grades of Recommendations 
Grades of Recommendations: 
A Directly based on Level I evidence 
B Directly based on Level II evidence or extrapolated recommendations from Level I evidence 
C 
Directly based on Level III evidence or extrapolated recommendations from Level I or II 
evidence 
D 
Directly based on Level IV evidence or extrapolated recommendations from Level I, II, or 
III evidence 
 










Smoking Self-Efficacy Questionnaire (SEQ-12)  
The following are some situations in which certain people might be tempted to smoke. Please 
indicate whether you are sure that you could refrain from smoking in each situation using one of 
the following answers:  
1 = Not at all sure 2 = Not very sure 3 = More or less sure 4 = Fairly sure 5 = Absolutely sure  
1. When I feel nervous _____  
2. When I feel depressed _____  
3. When I am angry _____  
4. When I feel very anxious _____  
5. When I want to think about a difficult problem _____  
6. When I feel the urge to smoke _____  
7. When having a drink with friends _____  
8. When celebrating something _____  
9. When drinking beer, wine, or other spirits _____  
10. When I am with smoker’s _____  
11. After a meal _____  
12. When having coffee or tea _____ 
 
Note. Etter, J., Bergman, M.., Humair, J., & Perneger, T. (2000). Development and validation of 
a scale measuring self-efficacy of current and former smokers. Addiction, 95(6), 901-913.) 
 
 





Fagerstrom Test for Nicotine Dependence 
Is smoking “just a habit” or are you addicted? Take this test and find out your level of 
dependence on nicotine. 
1. How soon after you wake up do you smoke your first cigarette? 
¨ After 60 minutes (0) 
¨ 31-60 minutes (1) 
¨ 6-30 minutes (2) 
¨ Within 5 minutes (3) 
2. Do you find it difficult to refrain from smoking in places where it is forbidden? 
¨ No (0) 
¨ Yes (1) 
3. Which cigarette would you hate most to give up? 
¨ The first in the morning (1) 
¨ Any other (0) 
4. How many cigarettes per day do you smoke? 
¨ 10 or less (0) 
¨ 11-20 (1) 
¨ 21-30 (2) 
¨ 31 or more (3) 
5. Do you smoke more frequently during the first hours after awakening than during the 
rest of the day? 
¨ No (0) 
¨ Yes (1) 
6. Do you smoke even if you are so ill that you are in bed most of the day? 
¨ No (0) 
¨ Yes (1) 
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Fagerstrom Test for Nicotine Dependence (cont.) 
Your score was:________ 
Your level of dependence on nicotine is: 
0-2 Very low dependence  6-7 High dependence 
3-4 Low dependence   8-10 Very high dependence 
5 Medium dependence 
Scores under 5: “Your level of nicotine dependence is still low. You should act now 
before your level of dependence increases.“ 
Score of 5: “Your level of nicotine dependence is moderate. If you don’t quit soon, 
your level of dependence on nicotine will increase until you may be seriously addicted. 
Act now to end your dependence on nicotine.” 
Score over 7: “Your level of dependence is high. You aren’t in control of your smoking 
– it is in control of you! When you make the decision to quit, you may want to talk with 
your doctor about nicotine replacement therapy or other medications to help you break 
your addiction.” 
Note.  Heatherton, T., Kozlowski, L., Frecker, R., Fagerstrom, K. (1991). The Fagerstrom test for 










Readiness to Change Questionnaire  
Readiness to Change Exercise 
Name _____________________________________  Date____________________ 
This exercise will help you understand how ready you are to change certain behaviors related to 
your health and wellbeing. The answers will help your coach determine what areas of your health 
are most important, as well as help you set realistic goals.  Please do not judge your answers, just 
try to be as truthful as possible. There is no right or wrong answers. 
In the first column, rank, on a scale of 1-10 how important the following behaviors are to you (1 
= not important at all and 10 = very important).  If the behavior is not applicable (i.e. you do not 
smoke), just write “NA’ in the box.  Keep in mind; something can be important to us, even if we 
struggle to change the behaviors.  If you think about something often, chances are it is important 
to you. 
In the second column, rank, on a scale of 1-10 how confident you are that you can make and 
maintain changes in these areas (“1” = “not confident at all” and “10” = “very confident/already 
part of my lifestyle”).   
 
BEHAVIOR IMPORTANCE CONFIDENCE 
Reduce/Cease Smoking   
Weight management   
Physical activity   
Nutrition   
Stress management   
Medication compliance (you 
take your medications as 
prescribed) 
  
Sleep   
 
                 1 = not important     1 = not confident 
                 10 = very important   10 = very confident 
                 NA = not applicable 
Your coach will discuss this with you more at your initial appointment.  
Note. Based on the Readiness to Change grid by Wellcoaches (2014) 
 
